103 related articles for article (PubMed ID: 7381836)
1. Synthesis and antitumor activity of cyclophosphamide analogues. 3. Preparation, molecular structure determination and anticancer screening of racemic cis- and trans-4-phenylcyclophosphamide.
Boyd VL; Zon G; Himes VL; Stalick JK; Mighell AD; Secor HV
J Med Chem; 1980 Apr; 23(4):372-5. PubMed ID: 7381836
[TBL] [Abstract][Full Text] [Related]
2. 5-Fluoro- and 5-chlorocyclophosphamide: synthesis, metabolism, and antitumor activity of the cis and trans isomers.
Foster AB; Jarman M; Kinas RW; van Maanen JM; Taylor GN; Gaston JL; Parkin A; Richardson AC
J Med Chem; 1981 Dec; 24(12):1399-403. PubMed ID: 7310816
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and antitumor activity of cyclophosphamide analogues. 4. Preparation, kinetic studies, and anticancer screening of "phenylketophosphamide" and similar compounds related to the cyclophosphamide metabolite aldophosphamide.
Ludeman SM; Boyd VL; Regan JB; Gallo KA; Zon G; Ishii K
J Med Chem; 1986 May; 29(5):716-27. PubMed ID: 3701785
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and antitumor properties of activated cyclophosphamide analogues.
Borch RF; Canute GW
J Med Chem; 1991 Oct; 34(10):3044-52. PubMed ID: 1920355
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and antitumor activity of analogues of ifosfamide modified in the N-(2-chloroethyl) group.
Misiura K; Kinas RW; Stec WJ; Kusnierczyk H; Radzikowski C; Sonoda A
J Med Chem; 1988 Jan; 31(1):226-30. PubMed ID: 3336021
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and antitumor evaluation of 4-ethoxycarbonyl cyclophosphamide analogs.
Foster EL
J Pharm Sci; 1978 May; 67(5):709-10. PubMed ID: 641817
[TBL] [Abstract][Full Text] [Related]
7. The metabolism and antitumour activity of the enantiomers of cis- and trans-4-methylcyclophosphamide.
Farmer PB; Jarman M; Facchinetti T; Pankiewicz K; Stec WJ
Chem Biol Interact; 1977 Jul; 18(1):47-57. PubMed ID: 890840
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and evaluation of 3-halocyclophosphamides and analogous compounds as novel anticancer "pro-prodrugs".
Zon G; Ludeman SM; Ozkan G; Chandrasegaran S; Hammer CF; Dickerson R; Mizuta K; Egan W
J Pharm Sci; 1983 Jun; 72(6):687-91. PubMed ID: 6875830
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and antitumor activity of cyclophosphamide analogues. 2. Preparation, hydrolytic studies, and anticancer screening of 5-bromocyclophosphamide, 3,5-dehydrocyclophosphamide, and related systems.
Ludeman SM; Zon G; Egan W
J Med Chem; 1979 Feb; 22(2):151-8. PubMed ID: 423194
[No Abstract] [Full Text] [Related]
10. Synthesis, structural characterization, and antitumor properties of a novel class of large-ring platinum(II) chelate complexes incorporating the cis-1,4-diaminocyclohexane ligand in a unique locked boat conformation.
Hoeschele JD; Showalter HD; Kraker AJ; Elliott WL; Roberts BJ; Kampf JW
J Med Chem; 1994 Aug; 37(17):2630-6. PubMed ID: 8064793
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and antitumor activity of cyclophosphamide analogs. 1. Benzo annulated cyclophosphamide and related systems.
Ludeman SM; Zon G
J Med Chem; 1975 Dec; 18(12):1251-3. PubMed ID: 1195278
[TBL] [Abstract][Full Text] [Related]
12. Synthesis of reactive metabolite-analogues of cyclophosphamide for comparisons of NMR kinetic parameters and anticancer screening data.
Ludeman SM; Boyd VL; Regan JB; Gallo KA; Zon G; Ishii K
Drugs Exp Clin Res; 1986; 12(6-7):527-32. PubMed ID: 3743371
[TBL] [Abstract][Full Text] [Related]
13. Isolation of cis- and trans-4-methylcyclophosphamide and antitumor evaluation in vivo.
Struck RF; Thorpe MC; Coburn WC; Kirk MC
Cancer Res; 1975 Nov; 35(11 Pt 1):3160-3. PubMed ID: 1182706
[TBL] [Abstract][Full Text] [Related]
14. In situ preparation and fate of cis-4-hydroxycyclophosphamide and aldophosphamide: 1H and 31P NMR evidence for equilibration of cis- and trans-4-hydroxycyclophosphamide with aldophosphamide and its hydrate in aqueous solution.
Borch RF; Hoye TR; Swanson TA
J Med Chem; 1984 Apr; 27(4):490-4. PubMed ID: 6708051
[TBL] [Abstract][Full Text] [Related]
15. Synthesis of analogues of N-(2-chloroethyl)-N'-(trans-4-methylcyclohexyl)-N-nitrosourea for evaluation as anticancer agents.
Johnston TP; McCaleb GS; Clayton SD; Frye JL; Krauth CA; Montgomery JA
J Med Chem; 1977 Feb; 20(2):279-90. PubMed ID: 836500
[TBL] [Abstract][Full Text] [Related]
16. Studies on cyclophosphamide metabolites and their related compounds. 2. Preparation of an active species of cyclophosphamide and related compounds.
Takamizawa A; Matsumoto S; Iwata T; Tochino Y; Katagiri K; Yamaguchi K
J Med Chem; 1975 Apr; 18(4):376-83. PubMed ID: 1121004
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and study of a spin-labeled cyclophosphamide analogue, 3-(1-oxy-2,2,6,6-tetramethyl-4-piperidinyl)cyclophosphamide.
Tsui FP; Robey FA; Engle TW; Ludeman SM; Zon G
J Med Chem; 1982 Sep; 25(9):1106-10. PubMed ID: 7131492
[TBL] [Abstract][Full Text] [Related]
18. Synthesis, stereochemistry and antitumor activity of 4-hydroperoxyisophosphamide (NSC-227114) and related compounds.
Takamizawa A; Matsumoto S; Iwata T; Makino I
Chem Pharm Bull (Tokyo); 1977 Aug; 25(8):1877-91. PubMed ID: 562722
[No Abstract] [Full Text] [Related]
19. NMR spectroscopic studies of intermediary metabolites of cyclophosphamide. A comprehensive kinetic analysis of the interconversion of cis- and trans-4-hydroxycyclophosphamide with aldophosphamide and the concomitant partitioning of aldophosphamide between irreversible fragmentation and reversible conjugation pathways.
Zon G; Ludeman SM; Brandt JA; Boyd VL; Ozkan G; Egan W; Shao KL
J Med Chem; 1984 Apr; 27(4):466-85. PubMed ID: 6708049
[TBL] [Abstract][Full Text] [Related]
20. Stereoselective preparation of six diastereomeric quatercyclopropanes from bicyclopropylidene and some derivatives.
von Seebach M; Kozhushkov SI; Schill H; Frank D; Boese R; Benet-Buchholz J; Yufit DS; de Meijere A
Chemistry; 2007; 13(1):167-77. PubMed ID: 17024706
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
